Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi Israel crowdsources new diabetes app

Collaborates with online patient network Camoni

Isreali social network health CamoniSanofi is collaborating with Camoni - an Israeli social network for patients - to crowdsource ideas for a new mobile app for people with diabetes.

The company is running an open competition for app ideas, allowing Camoni participants to discuss and rate those submitted.

Ronnie Birnbaum, Sanofi Israel's general manager, said: “In order to bring an app to answer the needs of users in the best way, we chose a model based on the 'wisdom of crowds'.

“[We] invited diabetics, their families, friends and anyone who touches the disease to offer application ideas, contribute from personal experience and share with us their needs.”

The ultimate goal is, Birnbaum said, to be able to launch an app that would be the “first of its kind, created by and for diabetics”.

The three-week app contest and campaign, which began on July 10, is being managed by Israeli digital health agency e-Pochonder.

While Sanofi said that this type of crowdsourcing initiative was the first of its kind, the campaign is not the company's first foray into the world of mobile apps.

In fact, Sanofi was among the first in pharma to use the technology, with its diabetes arm developing first the GoMeals iPhone app in 2009 and then, more recently, the iBGStar app for its iPhone-compatible blood glucose monitor of the same name.

23rd July 2013

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Established in 1993, Atlantis Healthcare provides unique solutions to address the issues of treatment non-adherence and patient self-management....

Latest intelligence

Online Physician Communities
Review: diabetes tweetchat
Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe...
access denied
Sales reps struggle to access doctors
Doctors continue to turn away from face-to-face visits from pharma sales reps and look instead towards mobile technology for information...
Online Physician Communities
Research finds doctors are optimistic about new diabetes drugs but concerned over rationing
New data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are...